20th May 2016 07:00
For filings with the FCA include the annex | |||||
For filings with issuer exclude the annex | |||||
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi | |||||
1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii | Oncimmune Holdings plc | ||||
2 Reason for the notification (please tick the appropriate box or boxes): | |||||
An acquisition or disposal of voting rights | √ | ||||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | |||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | |||||
An event changing the breakdown of voting rights | |||||
Other (please specify): |
| ||||
3. Full name of person(s) subject to thenotification obligation: iii | Aviva plc & its subsidiaries | ||||
4. Full name of shareholder(s) (if different from 3.):iv | Registered Holder:
BNY Norwich Union Nominees Limited 119,273*
Chase (GA Group) Nominees Limited 2,136,901* *Denotes direct interest | ||||
5. Date of the transaction and date onwhich the threshold is crossed orreached: v | 18 May 2016 | ||||
6. Date on which issuer notified: | 19 May 2016 | ||||
7. Threshold(s) that is/are crossed orreached: vi, vii | Nil Held to 4% Change at Direct Interest Level | ||||
8. Notified details: | |||||||||||
A: Voting rights attached to shares viii, ix | |||||||||||
Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation after the triggering transaction | |||||||||
NumberofShares | NumberofVotingRights | Numberof shares | Number of votingrights | % of voting rights x | |||||||
Direct | Direct xi | Indirect xii | Direct | Indirect | |||||||
Ordinary SharesGB00BYQ94H38 | Nil Held | Nil Held | 2,256,174 | 2,256,174 | Not disclosable | 4.42% | Not disclosable | ||||
B: Qualifying Financial Instruments | |||||||||||
Resulting situation after the triggering transaction | |||||||||||
Type of financialinstrument | Expirationdate xiii | Exercise/Conversion Period xiv | Number of votingrights that may beacquired if theinstrument isexercised/ converted. | % of votingrights | |||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | ||||||
Resulting situation after the triggering transaction | ||||||
Type of financialinstrument | Exercise price | Expiration date xvii | Exercise/Conversion period xviii | Number of voting rights instrument refers to
| % of voting rights xix, xx
| |
| Nominal | Delta | ||||
Total (A+B+C) | |
Number of voting rights | Percentage of voting rights |
2,256,174 | 4.42% |
9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi |
The voting rights are managed and controlled by Aviva Investors Global Services Limited, with the following chains of controlled undertakings:-
Aviva Investors Global Services Limited: · Aviva plc (Parent Company) · Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc) · Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited) · Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited)
|
Proxy Voting: | |
10. Name of the proxy holder: | See Section 4 |
11. Number of voting rights proxy holder will ceaseto hold: | |
12. Date on which proxy holder will cease to holdvoting rights: |
13. Additional information: | Figures are based on the total number of voting rights of 51,024,404 shares, as per the Company's Admission to Trading on the London Stock Exchange Announcement of 18 May 2015.
|
14. Contact name: | Neil Whittaker, Aviva plc |
15. Contact telephone number: | 01603 684420 |
Related Shares:
AvivaOncimmune